The Clearity Foundation will be joining with Ovarian Cancer Research Alliance

The Ovarian Cancer Research Alliance (OCRA) announced that it will merge with The Clearity Foundation, effective January 1, 2025.

This significant partnership unites two prominent organizations in ovarian cancer, combining OCRA’s expertise in research, advocacy, and patient support with Clearity’s focus on scientific education and direct support for women and families affected by ovarian cancer. The merger will allow OCRA to expand its services and resources for the ovarian and gynecologic cancer community.

On this occasion, Audra Moran, President and CEO at Ovarian Cancer Research Alliance, shared a post on LinkedIn:

“So thrilled to announce that our good friends at the Clearity Foundation will be joining with Ovarian Cancer Research Alliance allowing us to serve more patients and expand our suite of services together!”

Read further.
Source: Audra Moran/LinkedIn

More posts featuring Ovarian Cancer Research Alliance on oncodaily.com

The Ovarian Cancer Research Alliance (OCRA), founded in 1994, is the world’s largest ovarian cancer charity. It has invested over $110 million in research to end ovarian cancer. As the leading private funder of research, OCRA also advocates on Capitol Hill for federal funding and health policies that benefit patients and survivors.

Clearity aims to enhance the survival and quality of life for those affected by ovarian cancer, offering hope to patients and their families. Founded in 2008 by scientist and survivor Laura Shawver, Ph.D., Clearity seeks to transform ovarian cancer treatment. By analyzing medical history, tumor molecular profiles, and other diagnostics, Clearity provides personalized support to help women and their physicians choose the most effective treatment options.